Is now the time to Buy, Sell or Hold post stock Canopy Growth (CGC)?

: CGC | Canopy Growth Corporation  News, Ratings, and Charts

CGC – Canopy Growth remains a favorite among analysts for more than a few good reasons.

In a crowded crop of cannabis stocks Canopy Growth (NYSE:CGC) remains a favorite among analysts for more than a few good reasons. But the the price chart still suggests Canopy Growth Corporation (CGC - Get Rating) stock isn’t ready for picking. In fact, the stock could grow into a very profitable shorting opportunity. Let me explain.

Shares of Canopy Growth seemingly have everything going for it. The latest to promote that fact is investment firm Stifel. Analyst W. Andrew Carter initiated shares Thursday with a buy rating and price target of CAD $64 or an equivalent $47.77 USD for the NYSE-listed shares. At the same time Canopy Growth Corporation (CGC - Get Rating) stock was hailed as the “best investable opportunity” in cannabis.

Behind the bullish-sounding praise, Mr. Carter pointed out Canopy’s best-in-breed leadership and large-scale infrastructure in Canada. The company’s partnership with Constellation Brands (NYSE:STZ), Canopy’s multiple channels to profit from the U.S. market and its top-notch positioning for cashing in on global medicinal opportunities were also noted.

The problem with the approval is there’s nothing new under the sun here. Stifel’s recommendation states the obvious to anyone with more than a passing interest in Canopy Growth Corporation (CGC - Get Rating) stock over the past year. Further, given a meager sub $48 price target, which barely compensates investors for the week-to-week risk in owning a volatile name like Canopy Growth Corporation (CGC - Get Rating) stock, growing your dollars from a Canopy Growth Corporation (CGC - Get Rating) stock purchase today continues to look like tough business on the price chart.

Canopy Growth Corporation (CGC - Get Rating) Stock Daily Chart

Canopy’s impressive credentials on paper continues to be at odds with a volatile price chart and one with a knack for temperamental behavior. A recent warning in mid-May to simply watch Canopy Growth Corporation (CGC - Get Rating) from the sidelines was a good call as shares went on to shed roughly 15% at their recent lows. And I don’t see that pain as being over just yet either.

This week’s rally has reclaimed some of that lost value. The bad news is Canopy Growth Corporation (CGC - Get Rating) stock is now stationed beneath the 200-day simple moving average after breaking the key long-term and closely-watched trend line. Moreover, the move higher this week has formed a bearish flag whose low undercut a similar failed pattern from April, which incidentally found support off the same moving average.

The technical interpretation is this time bulls won’t be so lucky with the current bearish pattern given the extra layer of resistance. If I’m correct, Canopy Growth shares will also be in position for a much larger correction towards the December low.

For traders agreeable with this bearish outlook, I’d recommend shorting shares below $41. The modified entry is about 1% beneath Thursday’s doji closing print and should help trigger some bearish momentum out of the flag. The short is also contingent on Canopy Growth remaining below $43.50. This line in the sand allows for a necessary couple percent of wiggle room above the 200 SMA. Given Canopy Growth stock’s history of erratic and volatile price behavior, that’s sensible enough. Better yet, it also keeps this bearish play from getting smoked off and on the price chart.


Canopy Growth Corp. shares were unchanged in after-hours trading Monday. Year-to-date, Canopy Growth Corporation (CGC - Get Rating) has gained 62.86%, versus a 16.13% rise in the benchmark S&P 500 index during the same period.

Canopy Growth Corporation (CGC - Get Rating) currently has a StockNews.com POWR Rating of D (Sell), and is ranked #59 of 207 stocks in the Medical – Pharmaceuticals category.


This article is brought to you courtesy of Yahoo! Finance.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Top Stories on StockNews.com

NASDAQ: TLT | iShares 20+ Year Treasury Bond ETF News, Ratings, and Charts

What Does the Options Market Say About Interest Rates?

Why are investors so fixated on interest rates? If you follow the financial markets regularly, you'll notice how laser-focused the investment community is. See how the Options Market is responding to current interest rates.
: CGC | Canopy Growth Corporation  News, Ratings, and Charts

Should Investors Buy the Dip in Canopy Growth (CGC)?

As the entire sector sold off over these past few months, Canopy followed suit sliding from highs of $76 (CAD) all the way down into the $’30s recently.
NYSE: NVS | Novartis AG  News, Ratings, and Charts

Sweet 16 Safe Stocks for this Volatile Market

The bull market is still in place, but appetite for risk is low. Novartis (NVS) is just one of 16 stocks with the right ingredients to excel in this volatile environment.
NYSE: SPY | SPDR S&P 500 News, Ratings, and Charts

Does 1 Equation Hold the Key for Stock Prices?

At first I thought it was outrageous to believe this 1 equation is only that mattered for stock prices. Then I saw it happen plain as day in February 2016. Now I believe it will happen again.
NYSE: SPY | SPDR S&P 500 News, Ratings, and Charts

Trump Delays Chinese Tariffs, is He Just Postponing the Inevitable?

In this featured article, Trump's postponement of Chinese tariffs is examined. Could the President be postponing the inevitable? Continue reading for more details.

Read More Stories


More Canopy Growth Corporation (CGC) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All CGC News
Page generated in 1.3111 seconds.